Brief: Onxeo announces promising results from preclinical study of Beleodaq

Valerio Therapeutics SA

27/10/2016 17:01

Oct 27 (Reuters) - Onxeo  C4X.PA :  
    * Announces promising results from preclinical study of 
Beleodaq combination with checkpoint inhibitors 
 
 
Source text for Eikon:  ID:nBw9hlc6a  
     
Further company coverage:  C4X.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))